FDA inspection
Johnson & Johnson Pharmaceutical Research & Development, LLC: FDA inspection ending Aug 20, 2010
FDA inspection 676520 · Voluntary Action Indicated (VAI) · Raritan, NJ
Key facts
| Inspection ID | 676520 |
|---|---|
| Firm | Johnson & Johnson Pharmaceutical Research & Development, LLC |
| FEI number | 3006192174 |
| Address | 920 U.S. Highway 202, P.O. Box 300 |
| City | Raritan |
| State | NJ |
| ZIP | 08869 |
| Country | United States |
| Fiscal year | 2010 |
| Inspection end date | Aug 20, 2010 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Bioresearch Monitoring |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data